BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36606610)

  • 21. Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN).
    Beird HC; Khan M; Wang F; Alfayez M; Cai T; Zhao L; Khoury J; Futreal PA; Konopleva M; Pemmaraju N
    Blood Cancer J; 2019 Dec; 9(12):99. PubMed ID: 31811114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Lorenzi L; Lonardi S; Vairo D; Bernardelli A; Tomaselli M; Bugatti M; Licini S; Arisi M; Cerroni L; Tucci A; Vermi W; Giliani SC; Facchetti F
    Am J Surg Pathol; 2021 Oct; 45(10):1428-1438. PubMed ID: 34081040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blastic Plasmacytoid Dendritic Cell Neoplasm: Clinical Presentation and Diagnosis.
    Deconinck E; Petrella T; Garnache Ottou F
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):491-500. PubMed ID: 32336414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
    Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases.
    Vitte F; Fabiani B; Bénet C; Dalac S; Balme B; Delattre C; Vergier B; Beylot-Barry M; Vignon-Pennamen D; Ortonne N; Algros MP; Carlotti A; Samaleire D; Frouin E; Levy A; Laroche L; Theate I; Monnien F; Mugneret F; Petrella T
    Am J Surg Pathol; 2012 Sep; 36(9):1302-16. PubMed ID: 22895265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile.
    Martín-Martín L; López A; Vidriales B; Caballero MD; Rodrigues AS; Ferreira SI; Lima M; Almeida S; Valverde B; Martínez P; Ferrer A; Candeias J; Ruíz-Cabello F; Buadesa JM; Sempere A; Villamor N; Orfao A; Almeida J
    Oncotarget; 2015 Aug; 6(22):19204-16. PubMed ID: 26056082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
    Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
    Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm.
    Facchetti F; Pileri SA; Agostinelli C; Martelli MP; Paulli M; Venditti A; Martelli MF; Falini B
    Haematologica; 2009 Feb; 94(2):285-8. PubMed ID: 19066330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.
    Sapienza MR; Pileri S
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):511-521. PubMed ID: 32336416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumorous proliferations of plasmacytoid dendritic cells and Langerhans cells associated with acute myeloid leukaemia.
    Song HL; Huang WY; Chen YP; Chang KC
    Histopathology; 2012 Nov; 61(5):974-83. PubMed ID: 22804228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blastic plasmacytoid dendritic cell neoplasm accompanied by chronic myelomonocytic leukemia successfully treated with azacitidine].
    Sukegawa S; Sakata-Yanagimoto M; Matsuoka R; Momose H; Kiyoki Y; Noguchi M; Nakamura N; Watanabe R; Fujimoto M; Yokoyama Y; Nishikii H; Kato T; Kusakabe M; Kurita N; Obara N; Hasegawa Y; Chiba S
    Rinsho Ketsueki; 2018; 59(12):2567-2573. PubMed ID: 30626790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
    Wang W; Khoury JD; Miranda RN; Jorgensen JL; Xu J; Loghavi S; Li S; Pemmaraju N; Nguyen T; Medeiros LJ; Wang SA
    Haematologica; 2021 Apr; 106(4):1047-1055. PubMed ID: 32241840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoplasms derived from plasmacytoid dendritic cells.
    Facchetti F; Cigognetti M; Fisogni S; Rossi G; Lonardi S; Vermi W
    Mod Pathol; 2016 Feb; 29(2):98-111. PubMed ID: 26743477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmacytoid Dendritic Cell Infiltration in Acute Myeloid Leukemia.
    Zhu L; Wang P; Zhang W; Li Q; Xiong J; Li J; Deng X; Liu Y; Yang C; Kong P; Peng X; Zhong JF; Rao J; Zhang X
    Cancer Manag Res; 2020; 12():11411-11419. PubMed ID: 33192098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective.
    Hirner JP; O'Malley JT; LeBoeuf NR
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):501-509. PubMed ID: 32336415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia.
    Lucas N; Duchmann M; Rameau P; Noël F; Michea P; Saada V; Kosmider O; Pierron G; Fernandez-Zapico ME; Howard MT; King RL; Niyongere S; Diop MK; Fenaux P; Itzykson R; Willekens C; Ribrag V; Fontenay M; Padron E; Soumelis V; Droin N; Patnaik MM; Solary E
    Leukemia; 2019 Oct; 33(10):2466-2480. PubMed ID: 30894665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmacytoid Dendritic Cell Dermatosis Associated to Myeloproliferative/Myelodysplastic Neoplasms.
    Machan S; Alonso-Dominguez JM; Sánchez García FJ; Nieves Salgado R; Soto C; Castro Y; Pajares R; Manso R; Santonja C; Serrano Del Castillo C; Piris MA; Requena L; Rodríguez Pinilla SM
    Am J Surg Pathol; 2022 Dec; 46(12):1623-1632. PubMed ID: 36001453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional Landscape of CUT-Class Homeobox Genes in Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Nagel S; Rand U; Pommerenke C; Meyer C
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow : Summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016.
    Tzankov A; Hebeda K; Kremer M; Leguit R; Orazi A; van der Walt J; Gianelli U
    Ann Hematol; 2017 May; 96(5):765-777. PubMed ID: 28191591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated frequencies of leukemic myeloid and plasmacytoid dendritic cells in acute myeloid leukemia with the FLT3 internal tandem duplication.
    Rickmann M; Krauter J; Stamer K; Heuser M; Salguero G; Mischak-Weissinger E; Ganser A; Stripecke R
    Ann Hematol; 2011 Sep; 90(9):1047-58. PubMed ID: 21520003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.